• Highlights from ESMO 2023
  • Podcast Series: Discussions on NCCN Guidelines for MCL and CLL
  • Podcast Series: Discussions on CLL
  • And the Diagnosis is…
  • Highlights from ASCO 2024: Focus On Endometrial Cancer
  • Cancer Patient Resource Center
  • Patient-Matched Tumor-Normal Sequencing

Advanced Search

  • Featured:
  • Case Study: How Would You Treat…
  • HRD Testing in Advanced Ovarian Cancer
  • Genomic Profiling in Advanced Cancer Therapy Selection
  • Transforming colorectal cancer management with tumor informed ctDNA testing
  • Challenge One
  • Challenge Two

Challenge your diagnostic skills

Answer each quiz question to better understand the patient’s journey and determine the correct diagnosis.


  • 1 Question 1
  • 2 Question 2
  • 3 Question 3
  • 4 Final diagnosis
Question 3

Question 3 of 3 – Select the correct answer

Immunophenotyping of peripheral blood and karyotype analysis were performed as the next steps in the diagnostic workup.

  • Immunophenotyping of the peripheral blood by flow cytometry: showed 80% abnormal B cells that were positive for pan B-cell markers (CD19, cytoplasmic CD79a, CD20, and cytoplasmic CD22), CD45 (bright), human leukocyte antigen DR isotype (HLA-DR), cytoplasmic CD79b, CD10 (dim), and CD200. They were negative for CD3, CD5, CD7, CD34, TdT, CD103, CD38, surface CD22, surface CD79b, FMC7, and CD30.
  • Karyotype analysis: Examination of 20 metaphases showed a complex karyotype with some missing chromosomes, deletions, and translocations: 42,X,-X,del(1)(q36), t(4;17)(q27;q25),-8, t(12;21)(q24;q22),-14,-18, and del(19)t(9;19)(q11;p11)(20).

These findings, along with the clinical and radiologic data, suggested an unusual immunophenotype that posed a diagnostic challenge.

Choose your next step:

Continue
  • Previous
  • Next

© Copyright 2025. All Rights Reserved. Privacy Policy

Wolter Kluwer

Your Privacy

To give you the best possible experience we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy and Cookie Policy.

|
|

Cookie Policy

Information about our use of cookies

Wolters Kluwer ("we" or "us") wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain what personal information we collect, use and disclose.

Personal information means any data relating to an individual who can be identified, directly or indirectly, based on that information. This may include information such as names, contact details, (online) identification data, online identifiers, or other characteristics specific to that individual.

Read More